Literature DB >> 15660865

Changes in seroprevalence of hepatitis A in children and adolescents in Manisa, Turkey.

Selma Tosun1, Pelin Ertan, Erhun Kasirga, Umit Atman.   

Abstract

BACKGROUND: Hepatitis A virus (HAV), being an enteric transmitting virus wide world, occurs mostly in children of developing countries. However, the virus has recently been seen in adolescents and young adults worldwide. The aim of the present study was to evaluate the seroprevalence of the HAV infection in children and adolescents in Manisa, Turkey, and to verify whether the increased incidence of HAV infection in other parts of the world and Turkey generally is also true for the area of Manisa.
METHODS: The authors studied blood samples of 1395 adolescents and children aged between 6 months and 17 years from the Manisa area in order to evaluate the existence of anti-HAV antibodies using micro-ELISA test.
RESULTS: Total seropositivity was 44.6% while age related values were as followed: 6-23 months, 47.8%; 2-6 years, 23.7%; 7-10 years, 43.4%; 11-14 years, 52.4%; and 15-17 years, 76.6%. These results suggest that the seropositivity increases significantly among children at school age and also increases parallel to age.
CONCLUSIONS: According to these results, the authors concluded that there has been a shift of seropositivity from children to adolescents especially in families with an average or high socio-economical level.

Entities:  

Mesh:

Year:  2004        PMID: 15660865     DOI: 10.1111/j.1442-200x.2004.01969.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  5 in total

1.  Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.

Authors:  Eduardo Lazcano-Ponce; Carlos Conde-Gonzalez; Rosalba Rojas; Rodrigo DeAntonio; Luis Romano-Mazzotti; Yolanda Cervantes; Eduardo Ortega-Barria
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

2.  Relationship between antioxidant capacity and oxidative stress in children with acute hepatitis A.

Authors:  Mustafa Cemek; Semiha Dede; Fahri Bayiroglu; Huseyin Caksen; Fatma Cemek; Nihat Mert
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

3.  Interchangeability of a hepatitis A vaccine second dose: Avaxim 80 following a first dose of Vaqta 25 or Havrix 720 in children in Turkey.

Authors:  Ahmet Soysal; Ibrahim Gokçe; Tamer Pehlivan; Mustafa Bakir
Journal:  Eur J Pediatr       Date:  2007-02-22       Impact factor: 3.183

4.  Seroprevalence of hepatitis a in patients with chronic hepatitis C in isfahan province.

Authors:  Parisa Shoaei; Laleh Zeidabadinejad; Razieh Hassannejad; Behrooz Ataei; Majid Yaran; Nazila Kassaian; Zary Nokhodian; Maryam Foroughifar
Journal:  Int J Prev Med       Date:  2012-03

Review 5.  A review of the experience of childhood hepatitis A vaccination in Saudi Arabia and Turkey: implications for hepatitis A control and prevention in the Middle East and North African region.

Authors:  Selim Badur; Serdar Öztürk; Alev Ozakay; Mansour Khalaf; Debasish Saha; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2021-07-02       Impact factor: 4.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.